不同时机鼓室注射激素治疗全聋型突发性耳聋的临床效果比较

Abstract
Figure/Table
References (15)
Related Citation (15)

Download: PDF (0 KB) HTML (34 KB)
Export: BibTeX | EndNote (RIS)

Abstract Objective To compare the clinical effect of intratympanic hormone injection at different time in the treatment of total frequency type profound sudden sensorineural hearing loss.Methods Fifty-eight patients with total frequency type profound sudden sensorineural hearing loss treated in our hospital from February 2014 to January 2019 were selected as the subjects.According to the random number table method, the patients were divided into group Ⅰ(27 cases) and group Ⅱ(31 cases).Group Ⅰwas given intratympanic hormone injection immediately after oral administration, and group Ⅱwas given intratympanic hormone injection one week after oral administration.The auditory threshold, total effective rate and total incidence of complications were compared between the two groups.Results The auditory threshold of the two groups after treatment were lower than those before treatment, the differences were statistically significant (P＜0.05).There was no significant difference in auditory threshold between the two groups after treatment (P＞0.05).There were no significant differences in the total effective rate and total incidence of complications between the two groups (P＞0.05).Conclusion The clinical effect of intratympanic hormone injection at different time is similar for patients with total frequency type profound sudden sensorineural hearing loss, and it can be used according to the specific situation of patients.

Key words： Sudden sensorineural hearing loss Glucocorticoid Curative effect Tympanic injection

	Service

	E-mail this article
	Add to my bookshelf
	Add to citation manager
	E-mail Alert
	RSS
	Articles by authors
	GUO Shuang
	LI Da-wei
	ZHANG Dong-mei
	CUI Shi-hui

Cite this article:

GUO Shuang,LI Da-wei,ZHANG Dong-mei, et al. Clinical effect comparison of intratympanic hormone injection at different time in the treatment of total frequency type profound sudden sensorineural hearing loss[J]. 中国当代医药, 2020, 27(13): 97-100.

URL:

http://dangdaiyiyao.com/EN/ OR http://dangdaiyiyao.com/EN/Y2020/V27/I13/97

[1]	中国突发性聋多中心临床研究协作组.中国突发性聋分型治疗的多中心临床研究[J].中华耳鼻咽喉头颈外科杂志，2013，48（5）：355-361.
[3]	中华耳鼻咽喉头颈外科杂志编辑委员会，中华医学会耳鼻咽喉头颈外科学分会.突发性聋诊断和治疗指南（2015）[J].中华耳鼻咽喉头颈外科杂志，2015，50（6）：443-447.
[2]	Stachler RJ，Chandrasekhar SS，Archer SM，et al.Clinical practice guideline：sudden hearing loss[J].Otolaryngol Head Neck Surg，2012，146（3）：1-35.
[4]	Han X，Yin X，Du X，et al.Combined intratympanic and systemic use of steroids as a first-line treatment for sudden sensorineural hearing loss：a meta-analysis of randomized，controlled trials[J].Otol Neurotol，2017，38（4）：487-495.
[5]	余斌，蓝志杰，林玉婷，等.大剂量地塞米松治疗全聋型和平坦型突发性聋临床效果观察[J].临床合理用药杂志，2018，11（22）：37-38.
[6]	王娅，马永明，王悦，等.鼓室内注射甲强龙治疗不同类型突发性聋的临床疗效及预后影响因素分析[J].中国耳鼻咽喉头颈外科，2018，25（4）：207-210.
[7]	后婕，齐慧，戴艳红，等.激素抵抗对突发性聋治疗效果影响的临床观察[J].中华耳鼻咽喉头颈外科杂志，2017，52（8）：566-572.
[8]	Vanwijck F，Rogister F，Pierre Barriat S，et al.Intratympanic steroid therapy for refractory sudden sensory hearing loss：a 12-year experience with the Silverstein catheter[J].Acta Otolaryngol，2019，139（2）：111-116.
[9]	Chu CH，Chiou SR，Wang MC，et al.The efficacy of concurrent or sequential intravenous and intratympanic steroid for idiopathic sudden sensorineural hearing loss[J].Audiol Neurootol，2018，23（5）：277-284.
[10]	Tsounis M，Psillas G，Tsalighopoulos M，et al.Systemic，intratympanic and combined administration of steroids for sudden hearing loss.A prospective randomized multicenter trial[J].Eur Arch Otorhinolaryngol，2018，275（1）：103-110.
[11]	Demirhan H，Gokduman AR，Hamit B，et al.Contribution of intratympanic steroids in the primary treatment of sudden hearing loss[J].Acta Otolaryngol，2018，138（7）：648-651.
[12]	黄智强，李洁，喇新军，等.甲泼尼龙琥珀酸钠对突发性耳聋患者听力康复及血脂水平的影响[J].中国听力语言康复科学杂志，2017，15（6）：414-417.
[13]	李欣倩，王卫华，马兆鑫.糖皮质激素耳后注射治疗突发性聋的基础与临床研究[J].国际耳鼻咽喉头颈外科杂志，2018，42（6）：345-348.
[14]	班正锋.甲泼尼龙琥珀酸钠耳后注射治疗突发性耳聋的疗效观察[J].医学临床研究，2017，34（1）：171-173.
[15]	Ashtiani MK，Firouzi F，Bastaninejad S，et al.Efficacy of systemic and intratympanic corticosteroid combination therapy versus intratympanic or systemic therapy in patients with idiopathic sudden sensorineural hearing loss：a randomized controlled trial[J].Eur Arch Otorhinolaryngol，2018，275（1）：89-97.